Maximilian Linxweiler

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype”.

The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3758

N/A

0DataRank · unranked

126 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

The role of immune surveillance in malignant transformation of benign salivary gland tumors

Oncotarget(2021)10.18632/oncotarget.27900

N/A

0DataRank · unranked

3 citations

Jingming Wang, Luc G.T. Morris, Maximilian Linxweiler

Patterns of immune equilibrium and escape in indolent and progressing tumors

Cancer Cell(2023)10.1016/j.ccell.2023.06.003

N/A

0DataRank · unranked

5 citations

Maximilian Linxweiler, Fengshen Kuo, Jennifer L. Marti, Benjamin R. Roman, Behfar Ehdaie +3 more

Data from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

(2023)10.1158/1078-0432.c.6529017.v1

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1064

N/A

0DataRank · unranked

7 citations

Joris L. Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem, Maximilian Linxweiler +8 more